Attenuated TGE virus
AssigneeRichardson-Merrell Inc.
InventorSlobodan M. Djurickovic
Life of this patent
Estimating the term…
Loading patent…
AssigneeRichardson-Merrell Inc.
InventorSlobodan M. Djurickovic
Estimating the term…
A TGE virus is attenuated in organ culture of the colon of swine. After a number of passages, the resulting attenuated virus, if administered to swine will not seriously damage the villi of the small intestine, so that absorption of protein and other vital materials is not seriously hampered. The swine may suffer slight side effects, but are then immune to virulent TGE virus which is normally fatal to piglets.
An attenuated live transmissible gastroenteritis (TGE) virus vaccine for swine comprising an attenuated live transmissible gastroenteritis virus and a pharmaceutically acceptable carrier, wherein the TGE virus has been attenuated by passaging virulent TGE virus on pig colon organ culture for at least five serial passages;
A process for the preparation of attenuated live TGE virus composition adapted for introduction into the body of swine in order to confer immunity against subsequent infection by virulent TGE swine virus comprising:
A process for the preparation of attenuated live TGE virus vaccine comprising the steps of introducing virulent TGE virus strain into an organ culture maintenance medium containing viable cells of pig colon, incubating said organ culture medium by tissue culture techniques at 39.degree. C. for at least five serial passages, removing the colon cells and then harvesting the resulting attenuated live TGE virus-containing solution.
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Coronaviridae, e.g. avian infectious bronchitis virus: porcine transmissible gastroenteritis virus
Medicinal preparations containing antigens or antibodies: viral antigens
Virus: avirulent or attenuated
Characterised by the host/recipient, e.g. newborn with maternal antibodies: veterinary vaccine
Term ended 6 Sep 1994 (estimated)
USPTO file history isn’t available for this patent, so only indexed dates are shown.
1. Field of the Invention
The invention relates to the production of an attenuated virus of transmissible gastroenteritis of swine (TGE), the vaccine resulting from said attenuated virus and the administration of said vaccine.
2. The Prior Art